Expression and Association of the Yersinia pestis Translocon Proteins, YopB and YopD, Are Facilitated by Nanolipoprotein Particles
暂无分享,去创建一个
T. Laurence | B. Chromy | P. Hoeprich | T. Huser | V. Motin | M. Coleman | B. Segelke | Tingjuan Gao | E. Arroyo | F. Bourguet | C. Blanchette | J. Cappuccio | A. K. Hinz
[1] T. Laurence,et al. Quantifying interactions of a membrane protein embedded in a lipid nanodisc using fluorescence correlation spectroscopy. , 2014, Biophysical journal.
[2] T. Laurence,et al. Characterizing diffusion dynamics of a membrane protein associated with nanolipoproteins using fluorescence correlation spectroscopy , 2011, Protein science : a publication of the Protein Society.
[3] Andrey P. Anisimov,et al. Amino acid and structural variability of Yersinia pestis LcrV protein. , 2009, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.
[4] T. Sulchek,et al. Atomic force microscopy differentiates discrete size distributions between membrane protein containing and empty nanolipoprotein particles. , 2009, Biochimica et biophysica acta.
[5] T. Sulchek,et al. Cell-free Co-expression of Functional Membrane Proteins and Apolipoprotein, Forming Soluble Nanolipoprotein Particles*S , 2008, Molecular & Cellular Proteomics.
[6] Vicki L. Walsworth,et al. Hydrogen production by a hyperthermophilic membrane-bound hydrogenase in water-soluble nanolipoprotein particles. , 2008, Journal of the American Chemical Society.
[7] S. Smiley. Immune defense against pneumonic plague , 2008, Immunological reviews.
[8] J. Bliska,et al. Vaccination of Mice with a Yop Translocon Complex Elicits Antibodies That Are Protective against Infection with F1−Yersinia pestis , 2008, Infection and Immunity.
[9] T. Sulchek,et al. Insertion of membrane proteins into discoidal membranes using a cell-free protein expression approach. , 2008, Journal of proteome research.
[10] W. Swietnicki,et al. Yersinia pestis YopD 150-287 fragment is partially unfolded in the native state. , 2008, Protein expression and purification.
[11] T. Sulchek,et al. Different apolipoproteins impact nanolipoprotein particle formation. , 2007, Journal of the American Chemical Society.
[12] M. Aili,et al. Minimal YopB and YopD translocator secretion by Yersinia is sufficient for Yop-effector delivery into target cells. , 2007, Microbes and infection.
[13] G. Cornelis,et al. The type III secretion injectisome , 2006, Nature Reviews Microbiology.
[14] V. Dötsch,et al. Cell‐free expression as an emerging technique for the large scale production of integral membrane protein , 2006, The FEBS journal.
[15] L. J. Mota. Type III secretion gets an LcrV tip. , 2006, Trends in microbiology.
[16] S. Müller,et al. The V-Antigen of Yersinia Forms a Distinct Structure at the Tip of Injectisome Needles , 2005, Science.
[17] G. Cornelis,et al. Protective anti-V antibodies inhibit Pseudomonas and Yersinia translocon assembly within host membranes. , 2005, The Journal of infectious diseases.
[18] Michelle B. Ryndak,et al. Role of Predicted Transmembrane Domains for Type III Translocation, Pore Formation, and Signaling by the Yersinia pseudotuberculosis YopB Protein , 2005, Infection and Immunity.
[19] H. Wolf‐Watz,et al. The YopD Translocator of Yersinia pseudotuberculosis Is a Multifunctional Protein Comprised of Discrete Domains , 2004, Journal of bacteriology.
[20] C. Médigue,et al. Insights into the evolution of Yersinia pestis through whole-genome comparison with Yersinia pseudotuberculosis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[21] R. Brubaker. Interleukin-10 and Inhibition of Innate Immunity to Yersiniae: Roles of Yops and LcrV (V Antigen) , 2003, Infection and Immunity.
[22] I. Sethson,et al. Conformational analysis by CD and NMR spectroscopy of a peptide encompassing the amphipathic domain of YopD from Yersinia. , 2002, European journal of biochemistry.
[23] Tomio Ogasawara,et al. A bilayer cell‐free protein synthesis system for high‐throughput screening of gene products , 2002, FEBS letters.
[24] G. Plano,et al. Type III export: new uses for an old pathway , 2001, Molecular microbiology.
[25] R. Benz,et al. LcrV is a channel size‐determining component of the Yop effector translocon of Yersinia , 2001, Molecular microbiology.
[26] S. Miller,et al. The Salmonella type III secretion translocon protein SspC is inserted into the epithelial cell plasma membrane upon infection , 2000, Molecular microbiology.
[27] J. Ruysschaert,et al. Yersinia enterocolitica type III secretion–translocationsystem: channel formation by secreted Yops , 1999, The EMBO journal.
[28] S. Welkos,et al. Protective Efficacy of RecombinantYersinia Outer Proteins against Bubonic Plague Caused by Encapsulated and Nonencapsulated Yersinia pestis , 1999, Infection and Immunity.
[29] H. Wolf‐Watz,et al. YopD of Yersinia pseudotuberculosis is translocated into the cytosol of HeLa epithelial cells: evidence of a structural domain necessary for translocation , 1998, Molecular microbiology.
[30] J. Galán,et al. Supramolecular structure of the Salmonella typhimurium type III protein secretion system. , 1998, Science.
[31] T. Bergman,et al. YopB and YopD constitute a novel class of Yersinia Yop proteins , 1993, Infection and immunity.
[32] M. Telepnev,et al. The difference in the lcrV sequences between Y. pestis and Y. pseudotuberculosis and its application for characterization of Y. pseudotuberculosis strains. , 1992, Microbial pathogenesis.
[33] T. Sulchek,et al. Cell-free expression for nanolipoprotein particles: building a high-throughput membrane protein solubility platform. , 2009, Methods in molecular biology.
[34] B. Rupp,et al. Laboratory scale structural genomics , 2004, Journal of Structural and Functional Genomics.
[35] A. Friedlander,et al. Immune response to Yersinia outer proteins and other Yersinia pestis antigens after experimental plague infection in mice. , 1999, Infection and immunity.